Digestive Diseases and Sciences

, Volume 35, Issue 12, pp 1500–1504 | Cite as

Effects of cisapride on gastrointestinal transit in healthy humans

  • Jan Lysgård Madsen
Original Articles


It was the aim of this study to assess the effects of cisapride on gastrointestinal transit of solids in healthy humans. Twelve men received cisapride 10 mg or placebo orally four times a day in random, double-blind, crossover fashion. Transit measurements were performed with a new gamma camera technique. Cisapride reduced mean gastric emptying time of99mTc-labeled cellulose fiber {0.77 (0.69–1.12) hr [median (range)] vs 0.98 (0.63–1.95) hr; P<0.05 and 1- to 2- mm111In- labeled plastic particles [1.08 (0.50–1.42) hr vs 1.69 (0.59–3.03) hr; P<0.01]. Cisapride also decreased mean small intestinal transit time of cellulose fiber [2.11 (0.80–5.08) hr vs 2.82 (0.78–7.12) hr; P<0.05] and plastic particles [2.06 (1.13–5.13) hr vs 2.64 (1.18–7.04) hr; P<0.05]. However, cisapride increased mean large intestinal transit time of plastic particles [31 (13–75) hr vs 23 (12–36) hr; P<0.05]. In conclusion, oral cisapride 10 mg four times a day accelerates gastric emptying and small intestinal transit whereas this dose of cisapride seems to delay large intestinal transit of solids in healthy humans.

Key words

cisapride gastric emptying small intestinal transit large intestinal transit 99mTc-labeled cellulose fiber 111In-labeled plastic particles 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Reyntjens A, Verlinden M, De Coster R, Janisch HD, Smout A, De Cree J, Leempoels J, Verhaegen H: Clinical pharmacological evidence of cisapride's lack of antidopaminergic or direct cholinergic properties. Curr Ther Res 36:1045–1052, 1984Google Scholar
  2. 2.
    Schuurkes JAJ, Van Nueten JM, Van Daele PGH, Reyntjens AJ, Janssen PAJ: Motor-stimulating properties of cisapride on isolated gastrointestinal preparations of the guinea pig. J Pharmacol Exp Ther 234:775–783, 1985PubMedGoogle Scholar
  3. 3.
    Coremans G, Janssens J, Vantrappen G, Chaussade S, Ceccatelli P: Cisapride stimulates propulsive motility patterns in human jejunum. Dig Dis Sci 33:1512–1519, 1988PubMedGoogle Scholar
  4. 4.
    Rezende-Filho J, Di Lorenzo C, Dooley CP, Valenzuela JE: Cisapride stimulates antral motility and decreases biliary reflux in patients with severe dyspepsia. Dig Dis Sci 34:1057–1062, 1989PubMedGoogle Scholar
  5. 5.
    Tonini M, Galligan JJ, North RA: Effects of cisapride on cholinergic neurotransmission and propulsive motility in the guinea pig ileum. Gastroenterology 96:1257–1264, 1989PubMedGoogle Scholar
  6. 6.
    Snape WJ, Clarke DD, Gautsch E: Effect of cisapride on colonic smooth musclein vivo andin vitro. Gastroenterology 88:1592, 1985 (abstract)Google Scholar
  7. 7.
    Van Peer A, Woestenborghs R, Verlinden M, Meuldermans W, Heykants J: Pharmacokinetics of cisapride in healthy volunteers. Digestion 34:138, 1986 (abstract)Google Scholar
  8. 8.
    Madsen JL, Jensen M: Gastrointestinal transit of technetium-99m-labeled cellulose fiber and indium-111-labeled plastic particles. J Nucl Med 30:402–406, 1989PubMedGoogle Scholar
  9. 9.
    Geldof H, Van Der Schee EJ, Grashuis JL: Acute effects of cisapride and metoclopramide on gastric myoelectrical and motor activity in man. Gastroenterology 90:1425, 1986 (abstract)Google Scholar
  10. 10.
    Lux G, Katschinski P, Lederer P, Ellermann A: Digestive and interdigestive antroduodenal motility—influence of cisapride (C) and metoclopramide (M) in man. Gastroenterology 90:1527, 1986Google Scholar
  11. 11.
    Camilleri M, Brown ML, Malagelada J-R: Impaired transit of chyme in chronic intestinal pseudoobstruction. Correction by cisapride. Gastroenterology 91:619–626, 1986PubMedGoogle Scholar
  12. 12.
    Edwards CA, Holden S, Brown C, Read NW: Effect of cisapride on the gastrointestinal transit of a solid meal in normal human subjects. Gut 28:13–16, 1987PubMedGoogle Scholar
  13. 13.
    Stacher G, Steinringer H, Schneider C, Winklehner S, Mittelbach G, Gaupmann G: Effects of cisapride on jejunal motor activity in fasting healthy humans. Gastroenterology 90:1210–1216, 1986PubMedGoogle Scholar
  14. 14.
    Stacher G, Gaupmann G, Steinringer H, Schneider C, Stacher-Janotta G, Steiner-Mittelbach G, Abatzi T-A: Effects of cisapride on postcibal jejunal motor activity. Dig Dis Sci 34:1405–1410, 1989PubMedGoogle Scholar
  15. 15.
    Creytens G, Verlinden M, Reyntjens A: Double-blind study of cisapride in the treatment of chronic functional, nonspastic constipation. Digestion 34:158–159, 1986 (abstract)Google Scholar
  16. 16.
    Müller-Lissner SA, Bavarian Constipation Study Group: Treatment of chronic constipation with cisapride and placebo. Gut 28:1033–1038, 1987PubMedGoogle Scholar
  17. 17.
    Lee KY, Chey WY, You CH, Shah AN, Hamilton D: Effect of cisapride on the motility of gut in dogs and colonic transit time in dogs and humans. Gastroenterology 86:1157, 1984 (abstract)Google Scholar
  18. 18.
    Krevsky B, Malmud LS, Maurer AH, Somers MB, Siegel JA, Fisher RS: The effect of oral cisapride on colonic transit. Aliment Pharmacol Ther 1:293–304, 1987PubMedGoogle Scholar
  19. 19.
    Matthijs G, Peeters TL, Borman V, Vantrappen G: In vitro relaxation of rabbit duodenum induced by high concentrations of cisapride. Gastroenterology 92:1523, 1987 (abstract)Google Scholar
  20. 20.
    Chen HT, Wiley J, Owyang C: Mechanism of action of cisapride: Evidence for regional difference in the gastrointestinal tract. Gastroenterology 90:1370, 1986 (abstract)Google Scholar
  21. 21.
    Reboa G, Arnulfo G, Frascio M, Di Somma C, Pitto G, Berti-Riboli E: Colon motility and colo-anal reflexes in chronic idiopathic constipation. Effects of a novel enterokinetic agent cisapride. Eur J Clin Pharmacol 26:745–748, 1984PubMedGoogle Scholar
  22. 22.
    Krevsky B, Maurer AH, Malmud LS, Fisher RS: Cisapride accelerates colonic transit in constipated patients with colonic inertia. Am J Gastroenterol 84:882–887, 1989PubMedGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1990

Authors and Affiliations

  • Jan Lysgård Madsen
    • 1
    • 2
  1. 1.Department of Clinical Physiology and Nuclear MedicineGlostrup HospitalGlostrupDenmark
  2. 2.Department of Clinical Physiology and Nuclear MedicineRigshospitaletCopenhagenDenmark

Personalised recommendations